Clinton Bybee - Net Worth and Insider Trading

Clinton Bybee Net Worth

The estimated net worth of Clinton Bybee is at least $263 Million dollars as of 2024-05-24. Clinton Bybee is the Director of Impinj Inc and owns about 1,371,152 shares of Impinj Inc (PI) stock worth over $230 Million. Clinton Bybee is also the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $33 Million. Details can be seen in Clinton Bybee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Clinton Bybee has not made any transactions after 2017-11-09 and currently still holds the listed stock(s).

Transaction Summary of Clinton Bybee

To

Clinton Bybee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Clinton Bybee owns 34 companies in total, including Codiak BioSciences Inc (CDAKQ) , Metacrine Inc (MTCR) , and Impinj Inc (PI) among others .

Click here to see the complete history of Clinton Bybee’s form 4 insider trades.

Insider Ownership Summary of Clinton Bybee

Ticker Comapny Transaction Date Type of Owner
CDAKQ Codiak BioSciences Inc 2020-10-13 10 percent owner
MTCR Metacrine Inc 2020-09-15 10 percent owner
PI Impinj Inc 2017-11-09 director
2020-02-05 10 percent owner
2021-03-30 10 percent owner
2019-08-08 10 percent owner
2019-03-07 10 percent owner
2019-06-27 10 percent owner
2018-03-27 10 percent owner
2019-02-22 10 percent owner
2019-02-07 10 percent owner
2018-11-02 10 percent owner
2018-05-23 10 percent owner
2018-05-02 10 percent owner
2018-04-03 other: Former 10% owner
2020-11-20 10 percent owner
2016-10-11 director & 10 percent owner
2016-05-23 10 percent owner
2016-03-15 10 percent owner
2015-10-30 10 percent owner
2015-01-14 10 percent owner
2014-06-23 10 percent owner
2015-02-13 10 percent owner
2014-03-17 10 percent owner
2013-09-30 10 percent owner
2013-06-18 10 percent owner
2011-07-21 10 percent owner
2004-03-10 10 percent owner
2004-05-27 10 percent owner
2003-11-26 10 percent owner
2020-12-17 10 percent owner
2021-02-03 10 percent owner
2021-06-16 10 percent owner
2023-09-14 10 percent owner

Clinton Bybee Latest Holdings Summary

Clinton Bybee currently owns a total of 2 stocks. Among these stocks, Clinton Bybee owns 1,371,152 shares of Impinj Inc (PI) as of November 9, 2017, with a value of $230 Million and a weighting of 87.41%. Clinton Bybee also owns 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 27, 2004, with a value of $33 Million and a weighting of 12.59%.

Latest Holdings of Clinton Bybee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PI Impinj Inc 2017-11-09 1,371,152 167.75 230,010,748
ALNY Alnylam Pharmaceuticals Inc 2004-05-27 222,500 148.89 33,128,025

Holding Weightings of Clinton Bybee


Clinton Bybee Form 4 Trading Tracker

According to the SEC Form 4 filings, Clinton Bybee has made a total of 0 transactions in Impinj Inc (PI) over the past 5 years. The most-recent trade in Impinj Inc is the acquisition of 4,000 shares on November 9, 2017, which cost Clinton Bybee around $97,720.

According to the SEC Form 4 filings, Clinton Bybee has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on May 27, 2004, which brought Clinton Bybee around $0.

Insider Trading History of Clinton Bybee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Clinton Bybee Trading Performance

GuruFocus tracks the stock performance after each of Clinton Bybee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clinton Bybee is -51.02%. GuruFocus also compares Clinton Bybee's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clinton Bybee within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Clinton Bybee's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Clinton Bybee

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.51
Relative Return to S&P 500(%) -9.1

Clinton Bybee Ownership Network

Ownership Network List of Clinton Bybee

No Data

Ownership Network Relation of Clinton Bybee


Clinton Bybee Owned Company Details

What does Codiak BioSciences Inc do?

Who are the key executives at Codiak BioSciences Inc?

Clinton Bybee is the 10 percent owner of Codiak BioSciences Inc. Other key executives at Codiak BioSciences Inc include See Remarks Yalonda Howze , Chief Scientific Officer Sriram Sathyanarayanan , and See Remarks Nicole Barna .

Codiak BioSciences Inc (CDAKQ) Insider Trades Summary

Over the past 18 months, Clinton Bybee made no insider transaction in Codiak BioSciences Inc (CDAKQ). Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 61,535 shares made by Douglas E Williams , a net sale of 20,226 shares made by Linda Bain , and a net sale of 17,534 shares made by Sriram Sathyanarayanan .

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,081 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 129,081 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Codiak BioSciences Inc Insider Transactions

No Available Data

Clinton Bybee Mailing Address

Above is the net worth, insider trading, and ownership report for Clinton Bybee. You might contact Clinton Bybee via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.

Discussions on Clinton Bybee

No discussions yet.